A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2006
10/18/2006	CN1849287A Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
10/18/2006	CN1849118A Nonsedating alpha-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847260A Wheat germ protein depressor peptide desalting process
10/18/2006	CN1847236A 7,8-dihydroxy-2-oxo-2H-benzopyran derivative and its synthesis process and medicinal use
10/18/2006	CN1847230A Water soluble cinnarizine salt and its injection form
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1847228A Ozagrel ornithine salt and its injection form
10/18/2006	CN1846783A Compound piracetam-cerebral protein hydrolysate capsule and its prepn
10/18/2006	CN1846766A Freeze dried Mailuoning powder for injection
10/18/2006	CN1846763A Medicine composition for treating coronary heart disease and its prepn process
10/18/2006	CN1846762A Medicine composition for treating coronary heart disease and its prepn process
10/18/2006	CN1846760A Recipe and prepn process of physique strengthening and heart nourishing bolus
10/18/2006	CN1846759A Kidney invigorating and heart nourishing Hongfu ointment
10/18/2006	CN1846757A Chinese medicine powder capsule for treating hypertension, hyperlipemia and cardiac and cerebral vascular diseases
10/18/2006	CN1846749A Groundcherry oral liquid and its prepn process
10/18/2006	CN1846740A Medicine composition containing borneol and musk
10/18/2006	CN1846739A Hemiplegia treating Chinese medicine composition and its prepn process
10/18/2006	CN1846737A Medicine for treating cardiac and cerebral vascular diseases and its prepn process
10/18/2006	CN1846734A Prince's-feather prepn and its prepn process and application
10/18/2006	CN1846729A New film prepn form capable of being dissolved fast in oral cavity and its prepn process
10/18/2006	CN1846728A Dispersed tablet containing red sage and notoginseng and its prepn process
10/18/2006	CN1846727A Chinese medicine depressor
10/18/2006	CN1846722A Superfine Chinese medicine powder prepn for treating cardiovascular diseases and its prepn process
10/18/2006	CN1846721A Tranquilizing seven-leaf oral cavity disintegrated tablet
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846697A New use of angiotensin ii antagonists
10/18/2006	CN1280292C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
10/18/2006	CN1280291C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/18/2006	CN1280289C Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280275C Pyridione derivatives for tretment of atherosclerosis
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/18/2006	CN1280259C Aryl aniline beta-2 adrenergic receptor agonists
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279965C Traditional Chinese medicine preparation for treating cranial vascular diseases, its preparation method and application
10/18/2006	CN1279950C Compound formula earthworm capsule and its preparation technology
10/18/2006	CN1279946C Medicinal wine and its producing method
10/18/2006	CN1279944C Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation
10/18/2006	CN1279941C Medicine for preventing restenosis after interventional therapy of coronary heart disease and/or curing coronary heart disease and its preparation method
10/18/2006	CN1279935C Prpearation method of xueshuan xinmoining Chinese medicine for curing cerebrovascular diseases
10/18/2006	CN1279930C Applicaton of chinese angelica-root for preparing medicine for treating hypertension disease
10/18/2006	CN1279919C Pharmaceutical compositions containing ginsenoside, safflor yellow and its preparation and application
10/18/2006	CN1279916C 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds
10/18/2006	CN1279910C Milianone freeze dried preparation
10/18/2006	CN1279904C Vitamin C composition containing sodium vitamin C
10/18/2006	CN1279903C Preparation containing Gingkolactone and its producing process
10/18/2006	CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/18/2006	CN1279892C Fat emulsion injection of 'Xingnaojing' and its preparing process
10/17/2006	US7122679 Multicyclic compounds and the use thereof
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/17/2006	US7122567 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
10/17/2006	US7122556 Phenylalanine enamide derivatives
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
10/17/2006	US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/17/2006	US7122534 Aryl fused azapolycyclic compounds
10/17/2006	US7122525 Targeted therapeutics and uses thereof
10/17/2006	US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122318 measuring integrin expression in platelets of a patient to which the drug (especially a sulfonamide) is administered and determining influence of it on integrin expression in cells other than platelets based on the measured expression amount.
10/17/2006	US7122213 Composed of squash extract mixed with onion extract, having hypotensive effect and an anti-diabetic effect
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006	CA2294744C Multiple unit effervescent dosage form
10/17/2006	CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
10/17/2006	CA2207333C Use of nebivolol as an anti-atherogenic
10/12/2006	WO2006107902A2 Use of spirostenols to treat mitochondrial disorders
10/12/2006	WO2006107708A1 Treatment of disease caused by excess free hemoglobin
10/12/2006	WO2006107258A1 Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
10/12/2006	WO2006107257A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives
10/12/2006	WO2006107107A1 Myocardial protective agent comprising phospholipid liposome and method for prevention of myocardial disorder occurring under ischemia/reperfusion
10/12/2006	WO2006107059A1 Medicine for renal perfusion disorder
10/12/2006	WO2006106986A1 Agent for alleviating vascular insufficiency
10/12/2006	WO2006106963A1 Triamine derivative
10/12/2006	WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group
10/12/2006	WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006	WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding
10/12/2006	WO2006105811A1 Compounds useful as modulators of the proteasome activity
10/12/2006	WO2006105726A1 A composition for treating hypertension
10/12/2006	WO2006105708A1 A medicine composition for treating cardiac and cerebral vascular disease
10/12/2006	WO2006105666A1 Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis
10/12/2006	WO2006082412A3 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
10/12/2006	WO2006066879A3 Compounds with kv4 ion channel activity
10/12/2006	WO2006062962A3 Materials and methods for treating and managing plaque disease
10/12/2006	WO2006062402A3 Heat shock proteins (hsp) and supraventricular arrhythmia
10/12/2006	WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/12/2006	WO2006025070A3 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
10/12/2006	WO2006000583A3 Oral sustained release formulation of tedisamil with gastric retention properties
10/12/2006	US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis

1 ... 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 ... 1595